Disc Medicine (IRON) Selling, General & Administrative (2020 - 2026)

Disc Medicine (IRON) Selling, General & Administrative (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Oculis Holding AG 68,184.45 Bn 68,184.17 Bn - -10.08 Mn
2 Nanobiotix 1,953.19 Bn 1,953.13 Bn - -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn - 2.17 Mn
4 BeOne Medicines 474.39 Bn 469.59 Bn 1.35 Bn 555.10 Mn
5 Vertex Pharmaceuticals 123.45 Bn 116.21 Bn 2.59 Bn 493.70 Mn
6 Regeneron Pharmaceuticals 69.92 Bn 61.16 Bn 3.31 Bn 647.70 Mn
7 Belite Bio 63.43 Bn 63.43 Bn - 17.02 Mn
8 Argenx Se 56.67 Bn 51.49 Bn 1.41 Bn 1.13 Bn
9 Revolution Medicines 38.08 Bn 38.08 Bn - 101.25 Mn
10 Disc Medicine 2.90 Bn 2.90 Bn - 23.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 23.62 Mn
Dec 31, 2025 20.75 Mn
Sep 30, 2025 17.36 Mn
Jun 30, 2025 15.09 Mn
Mar 31, 2025 12.18 Mn
Dec 31, 2024 9.75 Mn
Sep 30, 2024 8.17 Mn
Jun 30, 2024 7.37 Mn
Mar 31, 2024 7.76 Mn
Dec 31, 2023 7.15 Mn
Sep 30, 2023 4.54 Mn
Jun 30, 2023 5.23 Mn
Mar 31, 2023 4.95 Mn
Dec 31, 2022 5.01 Mn
Sep 30, 2022 2.59 Mn
Jun 30, 2022 4.30 Mn
Mar 31, 2022 2.14 Mn
Dec 31, 2021 -9.41 Mn
Sep 30, 2021 5.00 Mn
Jun 30, 2021 5.48 Mn